<DOC>
	<DOC>NCT00234962</DOC>
	<brief_summary>The purpose of this study is to evaluate the effects of adherence on HIV antiviral response to treatment regimens containing Kaletra or other HIV protease inhibitors.</brief_summary>
	<brief_title>Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<criteria>Subject is documented HIV positive Subject is greater than or equal to 18 years of age. Subject currently on a regimen of either NNRTI + 2 Nucleoside Reverse Transcriptase Inhibitors NRTIs), two or three NRTIs who have failed regimen as evidenced by two consecutive viral loads with values over 1,000 copies/mL, the last one within the last three months, or Na√Øve subjects to ARV regimen who are required to begin a PI containing HAART regimen, or Subjects who have become intolerant to their current antiretroviral regimen and are required to be changed to a first time PI containing HAART regimen. Subject had laboratory testing within the previous three months and the most recent testing demonstrates all of the following: Hemoglobin &gt;8.0 g/dL; Absolute neutrophil count &gt;750 cells/mL; Platelet count &gt;20,000/mL; ALT or AST &lt;3 x Upper Limit of Normal (ULN); Creatinine &lt;1.5 x ULN; Triglycerides &lt;750 mg/dL. Subjects have no have evidence of grade III or IV adverse event or laboratory abnormality.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>HIV Infection</keyword>
	<keyword>HAART</keyword>
	<keyword>Lopinavir</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>Treatment Experienced</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>